Vaccinex annual return on equity
2022
2023
Vaccinex Return on Equity (ROE) Growth & History (VCNX)
Vaccinex's return on equity was −1,405.34% for fiscal 2023.
View full Vaccinex company overviewVaccinex annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −1,405.34% | −1090.94 pp |
| 2022 | 2022-12-31 | −314.40% | — |
Vaccinex quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q1.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2024-03-31 | −2,265.70% | −2135.00 pp |
| Q2 2023 | 2023-06-30 | −714.21% | −674.53 pp |
| Q1 2023 | 2023-03-31 | −130.70% | −91.76 pp |
| Q4 2022 | 2022-12-31 | −88.23% | −40.24 pp |
| Q3 2022 | 2022-09-30 | −55.14% | −19.03 pp |
| Q2 2022 | 2022-06-30 | −39.68% | +27.54 pp |
| Q1 2022 | 2022-03-31 | −38.94% | — |
| Q4 2021 | 2021-12-31 | −47.98% | — |
| Q3 2021 | 2021-09-30 | −36.12% | — |
| Q2 2021 | 2021-06-30 | −67.23% | — |
Vaccinex return on equity trends
Between the periods ended 2022-12-31 and 2023-12-31, Vaccinex's return on equity decreased from −314.40% to −1,405.34%, a change of −1090.94 percentage points. The latest reported quarter, Q1 2024, shows −2,265.70%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗